Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT01853553 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

ADPKD

Interventions

DRUG: Spironolactone
DRUG: Sugar pill

Sponsor

University of Colorado, Denver

Collaborators

[object Object]